Global Digital PCR and Real-time PCR Market

Digital PCR and Real-time PCR Comprehensive Study by Type (Instruments, Reagents), Application (Clinical (Pathogen Testing, Blood Screening, Oncology Testing, Others), Research, Forensic and Others), End-user (Hospitals, Diagnostic Labs, Academia, Pharma-Biotech, CRO), Solution (Software, Services) Players and Region - Global Market Outlook to 2026

Digital PCR and Real-time PCR Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Digital PCR and Real-time PCR Market?

Digital PCR (dPCR) counts individual molecules for absolute quantification by dividing a sample into many individual real-time PCR reactions. Digital PCR and real-time PCR market have high growth prospects owing to growing healthcare infrastructure and increasing demand from the developing economies. Further, emphasizing on the development of portable and compact PCR devices and technological advancement expected to drive the demand for digital PCR and real-time PCR market over the forecasted period.

The market study is being classified by Type (Instruments and Reagents), by Application (Clinical [Pathogen Testing, Blood Screening, Oncology Testing, Others], Research and Forensic and Others) and major geographies with country level break-up.

Thermo Fisher Scientific, Inc. (United States), F. Hoffman-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (United States), QIAGEN N.V. (Germany), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (United States), BioMérieux S.A. (France), Fluidigm Corporation (United States), Danaher Corporation (United States), Abbott Laboratories (United States), Merck KGaA (Germany) and Becton Dickinson and Company (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Promega Corporation (United States), Eppendorf AG (Germany) and Analytik Jena AG (Germany).

Leading global players are focusing on strategic partnerships to improve their products. In addition, companies are focusing on increasing their client base to strengthen market position and to enhance product offerings. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Digital PCR and Real-time PCR market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Digital PCR and Real-time PCR market by Type, Application and Region.

On the basis of geography, the market of Digital PCR and Real-time PCR has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Growing Prevalence of Genetic Disorders
  • Government Initiatives for Human Genome Project

Market Trend
  • Emphasizing On Development of Portable and Compact PCR Devices
  • Technological Advancement in the PCR Devices

Restraints
  • High Cost Associated With Digital PCR and Real-Time PCR
  • Stringent Government Regulations Regarding PCR Devices

Opportunities
  • Increasing Demand for Plant Derived To Genome-Based Drug Discovery
  • Growing Healthcare Infrastructure in the Developing Economies

Challenges
  • Lack of Advanced Medical in Facilities in the Emerging Economies



“PCR/qPCR/dPCR Assay Design, assays that are used in regulated environments must be taken through analytical validation and documentation in accordance with ICH guidelines that are recommended for adoption by the regulatory bodies of the European Union, Japan and USA6 for registration of pharmaceuticals for human use.”

Key Target Audience
Hospitals and Diagnostic Centers, Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, Forensic Laboratories and Others

Report Objectives / Segmentation Covered

By Type
  • Instruments
  • Reagents
By Application
  • Clinical [Pathogen Testing, Blood Screening, Oncology Testing, Others]
  • Research
  • Forensic and Others
By End-user
  • Hospitals
  • Diagnostic Labs
  • Academia
  • Pharma-Biotech
  • CRO

By Solution
  • Software
  • Services

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Prevalence of Genetic Disorders
      • 3.2.2. Government Initiatives for Human Genome Project
    • 3.3. Market Challenges
      • 3.3.1. Lack of Advanced Medical in Facilities in the Emerging Economies
    • 3.4. Market Trends
      • 3.4.1. Emphasizing On Development of Portable and Compact PCR Devices
      • 3.4.2. Technological Advancement in the PCR Devices
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Digital PCR and Real-time PCR, by Type, Application, End-user, Solution and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Digital PCR and Real-time PCR (Value)
      • 5.2.1. Global Digital PCR and Real-time PCR by: Type (Value)
        • 5.2.1.1. Instruments
        • 5.2.1.2. Reagents
      • 5.2.2. Global Digital PCR and Real-time PCR by: Application (Value)
        • 5.2.2.1. Clinical [Pathogen Testing, Blood Screening, Oncology Testing, Others]
        • 5.2.2.2. Research
        • 5.2.2.3. Forensic and Others
      • 5.2.3. Global Digital PCR and Real-time PCR by: End-user (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Diagnostic Labs
        • 5.2.3.3. Academia
        • 5.2.3.4. Pharma-Biotech
        • 5.2.3.5. CRO
      • 5.2.4. Global Digital PCR and Real-time PCR by: Solution (Value)
        • 5.2.4.1. Software
        • 5.2.4.2. Services
      • 5.2.5. Global Digital PCR and Real-time PCR Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Digital PCR and Real-time PCR (Price)
      • 5.3.1. Global Digital PCR and Real-time PCR by: Type (Price)
  • 6. Digital PCR and Real-time PCR: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Thermo Fisher Scientific, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. F. Hoffman-La Roche Ltd. (Switzerland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Bio-Rad Laboratories, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. QIAGEN N.V. (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Takara Bio, Inc. (Japan)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Agilent Technologies, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. BioMérieux S.A. (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Fluidigm Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Danaher Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Abbott Laboratories (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Merck KGaA (Germany)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Becton Dickinson and Company (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Digital PCR and Real-time PCR Sale, by Type, Application, End-user, Solution and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Digital PCR and Real-time PCR (Value)
      • 7.2.1. Global Digital PCR and Real-time PCR by: Type (Value)
        • 7.2.1.1. Instruments
        • 7.2.1.2. Reagents
      • 7.2.2. Global Digital PCR and Real-time PCR by: Application (Value)
        • 7.2.2.1. Clinical [Pathogen Testing, Blood Screening, Oncology Testing, Others]
        • 7.2.2.2. Research
        • 7.2.2.3. Forensic and Others
      • 7.2.3. Global Digital PCR and Real-time PCR by: End-user (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Diagnostic Labs
        • 7.2.3.3. Academia
        • 7.2.3.4. Pharma-Biotech
        • 7.2.3.5. CRO
      • 7.2.4. Global Digital PCR and Real-time PCR by: Solution (Value)
        • 7.2.4.1. Software
        • 7.2.4.2. Services
      • 7.2.5. Global Digital PCR and Real-time PCR Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Digital PCR and Real-time PCR (Price)
      • 7.3.1. Global Digital PCR and Real-time PCR by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Digital PCR and Real-time PCR: by Type(USD Million)
  • Table 2. Digital PCR and Real-time PCR Instruments , by Region USD Million (2015-2020)
  • Table 3. Digital PCR and Real-time PCR Reagents , by Region USD Million (2015-2020)
  • Table 4. Digital PCR and Real-time PCR: by Application(USD Million)
  • Table 5. Digital PCR and Real-time PCR Clinical [Pathogen Testing, Blood Screening, Oncology Testing, Others] , by Region USD Million (2015-2020)
  • Table 6. Digital PCR and Real-time PCR Research , by Region USD Million (2015-2020)
  • Table 7. Digital PCR and Real-time PCR Forensic and Others , by Region USD Million (2015-2020)
  • Table 8. Digital PCR and Real-time PCR: by End-user(USD Million)
  • Table 9. Digital PCR and Real-time PCR Hospitals , by Region USD Million (2015-2020)
  • Table 10. Digital PCR and Real-time PCR Diagnostic Labs , by Region USD Million (2015-2020)
  • Table 11. Digital PCR and Real-time PCR Academia , by Region USD Million (2015-2020)
  • Table 12. Digital PCR and Real-time PCR Pharma-Biotech , by Region USD Million (2015-2020)
  • Table 13. Digital PCR and Real-time PCR CRO , by Region USD Million (2015-2020)
  • Table 14. Digital PCR and Real-time PCR: by Solution(USD Million)
  • Table 15. Digital PCR and Real-time PCR Software , by Region USD Million (2015-2020)
  • Table 16. Digital PCR and Real-time PCR Services , by Region USD Million (2015-2020)
  • Table 17. South America Digital PCR and Real-time PCR, by Country USD Million (2015-2020)
  • Table 18. South America Digital PCR and Real-time PCR, by Type USD Million (2015-2020)
  • Table 19. South America Digital PCR and Real-time PCR, by Application USD Million (2015-2020)
  • Table 20. South America Digital PCR and Real-time PCR, by End-user USD Million (2015-2020)
  • Table 21. South America Digital PCR and Real-time PCR, by Solution USD Million (2015-2020)
  • Table 22. Brazil Digital PCR and Real-time PCR, by Type USD Million (2015-2020)
  • Table 23. Brazil Digital PCR and Real-time PCR, by Application USD Million (2015-2020)
  • Table 24. Brazil Digital PCR and Real-time PCR, by End-user USD Million (2015-2020)
  • Table 25. Brazil Digital PCR and Real-time PCR, by Solution USD Million (2015-2020)
  • Table 26. Argentina Digital PCR and Real-time PCR, by Type USD Million (2015-2020)
  • Table 27. Argentina Digital PCR and Real-time PCR, by Application USD Million (2015-2020)
  • Table 28. Argentina Digital PCR and Real-time PCR, by End-user USD Million (2015-2020)
  • Table 29. Argentina Digital PCR and Real-time PCR, by Solution USD Million (2015-2020)
  • Table 30. Rest of South America Digital PCR and Real-time PCR, by Type USD Million (2015-2020)
  • Table 31. Rest of South America Digital PCR and Real-time PCR, by Application USD Million (2015-2020)
  • Table 32. Rest of South America Digital PCR and Real-time PCR, by End-user USD Million (2015-2020)
  • Table 33. Rest of South America Digital PCR and Real-time PCR, by Solution USD Million (2015-2020)
  • Table 34. Asia Pacific Digital PCR and Real-time PCR, by Country USD Million (2015-2020)
  • Table 35. Asia Pacific Digital PCR and Real-time PCR, by Type USD Million (2015-2020)
  • Table 36. Asia Pacific Digital PCR and Real-time PCR, by Application USD Million (2015-2020)
  • Table 37. Asia Pacific Digital PCR and Real-time PCR, by End-user USD Million (2015-2020)
  • Table 38. Asia Pacific Digital PCR and Real-time PCR, by Solution USD Million (2015-2020)
  • Table 39. China Digital PCR and Real-time PCR, by Type USD Million (2015-2020)
  • Table 40. China Digital PCR and Real-time PCR, by Application USD Million (2015-2020)
  • Table 41. China Digital PCR and Real-time PCR, by End-user USD Million (2015-2020)
  • Table 42. China Digital PCR and Real-time PCR, by Solution USD Million (2015-2020)
  • Table 43. Japan Digital PCR and Real-time PCR, by Type USD Million (2015-2020)
  • Table 44. Japan Digital PCR and Real-time PCR, by Application USD Million (2015-2020)
  • Table 45. Japan Digital PCR and Real-time PCR, by End-user USD Million (2015-2020)
  • Table 46. Japan Digital PCR and Real-time PCR, by Solution USD Million (2015-2020)
  • Table 47. India Digital PCR and Real-time PCR, by Type USD Million (2015-2020)
  • Table 48. India Digital PCR and Real-time PCR, by Application USD Million (2015-2020)
  • Table 49. India Digital PCR and Real-time PCR, by End-user USD Million (2015-2020)
  • Table 50. India Digital PCR and Real-time PCR, by Solution USD Million (2015-2020)
  • Table 51. South Korea Digital PCR and Real-time PCR, by Type USD Million (2015-2020)
  • Table 52. South Korea Digital PCR and Real-time PCR, by Application USD Million (2015-2020)
  • Table 53. South Korea Digital PCR and Real-time PCR, by End-user USD Million (2015-2020)
  • Table 54. South Korea Digital PCR and Real-time PCR, by Solution USD Million (2015-2020)
  • Table 55. Taiwan Digital PCR and Real-time PCR, by Type USD Million (2015-2020)
  • Table 56. Taiwan Digital PCR and Real-time PCR, by Application USD Million (2015-2020)
  • Table 57. Taiwan Digital PCR and Real-time PCR, by End-user USD Million (2015-2020)
  • Table 58. Taiwan Digital PCR and Real-time PCR, by Solution USD Million (2015-2020)
  • Table 59. Australia Digital PCR and Real-time PCR, by Type USD Million (2015-2020)
  • Table 60. Australia Digital PCR and Real-time PCR, by Application USD Million (2015-2020)
  • Table 61. Australia Digital PCR and Real-time PCR, by End-user USD Million (2015-2020)
  • Table 62. Australia Digital PCR and Real-time PCR, by Solution USD Million (2015-2020)
  • Table 63. Rest of Asia-Pacific Digital PCR and Real-time PCR, by Type USD Million (2015-2020)
  • Table 64. Rest of Asia-Pacific Digital PCR and Real-time PCR, by Application USD Million (2015-2020)
  • Table 65. Rest of Asia-Pacific Digital PCR and Real-time PCR, by End-user USD Million (2015-2020)
  • Table 66. Rest of Asia-Pacific Digital PCR and Real-time PCR, by Solution USD Million (2015-2020)
  • Table 67. Europe Digital PCR and Real-time PCR, by Country USD Million (2015-2020)
  • Table 68. Europe Digital PCR and Real-time PCR, by Type USD Million (2015-2020)
  • Table 69. Europe Digital PCR and Real-time PCR, by Application USD Million (2015-2020)
  • Table 70. Europe Digital PCR and Real-time PCR, by End-user USD Million (2015-2020)
  • Table 71. Europe Digital PCR and Real-time PCR, by Solution USD Million (2015-2020)
  • Table 72. Germany Digital PCR and Real-time PCR, by Type USD Million (2015-2020)
  • Table 73. Germany Digital PCR and Real-time PCR, by Application USD Million (2015-2020)
  • Table 74. Germany Digital PCR and Real-time PCR, by End-user USD Million (2015-2020)
  • Table 75. Germany Digital PCR and Real-time PCR, by Solution USD Million (2015-2020)
  • Table 76. France Digital PCR and Real-time PCR, by Type USD Million (2015-2020)
  • Table 77. France Digital PCR and Real-time PCR, by Application USD Million (2015-2020)
  • Table 78. France Digital PCR and Real-time PCR, by End-user USD Million (2015-2020)
  • Table 79. France Digital PCR and Real-time PCR, by Solution USD Million (2015-2020)
  • Table 80. Italy Digital PCR and Real-time PCR, by Type USD Million (2015-2020)
  • Table 81. Italy Digital PCR and Real-time PCR, by Application USD Million (2015-2020)
  • Table 82. Italy Digital PCR and Real-time PCR, by End-user USD Million (2015-2020)
  • Table 83. Italy Digital PCR and Real-time PCR, by Solution USD Million (2015-2020)
  • Table 84. United Kingdom Digital PCR and Real-time PCR, by Type USD Million (2015-2020)
  • Table 85. United Kingdom Digital PCR and Real-time PCR, by Application USD Million (2015-2020)
  • Table 86. United Kingdom Digital PCR and Real-time PCR, by End-user USD Million (2015-2020)
  • Table 87. United Kingdom Digital PCR and Real-time PCR, by Solution USD Million (2015-2020)
  • Table 88. Netherlands Digital PCR and Real-time PCR, by Type USD Million (2015-2020)
  • Table 89. Netherlands Digital PCR and Real-time PCR, by Application USD Million (2015-2020)
  • Table 90. Netherlands Digital PCR and Real-time PCR, by End-user USD Million (2015-2020)
  • Table 91. Netherlands Digital PCR and Real-time PCR, by Solution USD Million (2015-2020)
  • Table 92. Rest of Europe Digital PCR and Real-time PCR, by Type USD Million (2015-2020)
  • Table 93. Rest of Europe Digital PCR and Real-time PCR, by Application USD Million (2015-2020)
  • Table 94. Rest of Europe Digital PCR and Real-time PCR, by End-user USD Million (2015-2020)
  • Table 95. Rest of Europe Digital PCR and Real-time PCR, by Solution USD Million (2015-2020)
  • Table 96. MEA Digital PCR and Real-time PCR, by Country USD Million (2015-2020)
  • Table 97. MEA Digital PCR and Real-time PCR, by Type USD Million (2015-2020)
  • Table 98. MEA Digital PCR and Real-time PCR, by Application USD Million (2015-2020)
  • Table 99. MEA Digital PCR and Real-time PCR, by End-user USD Million (2015-2020)
  • Table 100. MEA Digital PCR and Real-time PCR, by Solution USD Million (2015-2020)
  • Table 101. Middle East Digital PCR and Real-time PCR, by Type USD Million (2015-2020)
  • Table 102. Middle East Digital PCR and Real-time PCR, by Application USD Million (2015-2020)
  • Table 103. Middle East Digital PCR and Real-time PCR, by End-user USD Million (2015-2020)
  • Table 104. Middle East Digital PCR and Real-time PCR, by Solution USD Million (2015-2020)
  • Table 105. Africa Digital PCR and Real-time PCR, by Type USD Million (2015-2020)
  • Table 106. Africa Digital PCR and Real-time PCR, by Application USD Million (2015-2020)
  • Table 107. Africa Digital PCR and Real-time PCR, by End-user USD Million (2015-2020)
  • Table 108. Africa Digital PCR and Real-time PCR, by Solution USD Million (2015-2020)
  • Table 109. North America Digital PCR and Real-time PCR, by Country USD Million (2015-2020)
  • Table 110. North America Digital PCR and Real-time PCR, by Type USD Million (2015-2020)
  • Table 111. North America Digital PCR and Real-time PCR, by Application USD Million (2015-2020)
  • Table 112. North America Digital PCR and Real-time PCR, by End-user USD Million (2015-2020)
  • Table 113. North America Digital PCR and Real-time PCR, by Solution USD Million (2015-2020)
  • Table 114. United States Digital PCR and Real-time PCR, by Type USD Million (2015-2020)
  • Table 115. United States Digital PCR and Real-time PCR, by Application USD Million (2015-2020)
  • Table 116. United States Digital PCR and Real-time PCR, by End-user USD Million (2015-2020)
  • Table 117. United States Digital PCR and Real-time PCR, by Solution USD Million (2015-2020)
  • Table 118. Canada Digital PCR and Real-time PCR, by Type USD Million (2015-2020)
  • Table 119. Canada Digital PCR and Real-time PCR, by Application USD Million (2015-2020)
  • Table 120. Canada Digital PCR and Real-time PCR, by End-user USD Million (2015-2020)
  • Table 121. Canada Digital PCR and Real-time PCR, by Solution USD Million (2015-2020)
  • Table 122. Mexico Digital PCR and Real-time PCR, by Type USD Million (2015-2020)
  • Table 123. Mexico Digital PCR and Real-time PCR, by Application USD Million (2015-2020)
  • Table 124. Mexico Digital PCR and Real-time PCR, by End-user USD Million (2015-2020)
  • Table 125. Mexico Digital PCR and Real-time PCR, by Solution USD Million (2015-2020)
  • Table 126. Digital PCR and Real-time PCR: by Type(USD/Units)
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Digital PCR and Real-time PCR: by Type(USD Million)
  • Table 140. Digital PCR and Real-time PCR Instruments , by Region USD Million (2021-2026)
  • Table 141. Digital PCR and Real-time PCR Reagents , by Region USD Million (2021-2026)
  • Table 142. Digital PCR and Real-time PCR: by Application(USD Million)
  • Table 143. Digital PCR and Real-time PCR Clinical [Pathogen Testing, Blood Screening, Oncology Testing, Others] , by Region USD Million (2021-2026)
  • Table 144. Digital PCR and Real-time PCR Research , by Region USD Million (2021-2026)
  • Table 145. Digital PCR and Real-time PCR Forensic and Others , by Region USD Million (2021-2026)
  • Table 146. Digital PCR and Real-time PCR: by End-user(USD Million)
  • Table 147. Digital PCR and Real-time PCR Hospitals , by Region USD Million (2021-2026)
  • Table 148. Digital PCR and Real-time PCR Diagnostic Labs , by Region USD Million (2021-2026)
  • Table 149. Digital PCR and Real-time PCR Academia , by Region USD Million (2021-2026)
  • Table 150. Digital PCR and Real-time PCR Pharma-Biotech , by Region USD Million (2021-2026)
  • Table 151. Digital PCR and Real-time PCR CRO , by Region USD Million (2021-2026)
  • Table 152. Digital PCR and Real-time PCR: by Solution(USD Million)
  • Table 153. Digital PCR and Real-time PCR Software , by Region USD Million (2021-2026)
  • Table 154. Digital PCR and Real-time PCR Services , by Region USD Million (2021-2026)
  • Table 155. South America Digital PCR and Real-time PCR, by Country USD Million (2021-2026)
  • Table 156. South America Digital PCR and Real-time PCR, by Type USD Million (2021-2026)
  • Table 157. South America Digital PCR and Real-time PCR, by Application USD Million (2021-2026)
  • Table 158. South America Digital PCR and Real-time PCR, by End-user USD Million (2021-2026)
  • Table 159. South America Digital PCR and Real-time PCR, by Solution USD Million (2021-2026)
  • Table 160. Brazil Digital PCR and Real-time PCR, by Type USD Million (2021-2026)
  • Table 161. Brazil Digital PCR and Real-time PCR, by Application USD Million (2021-2026)
  • Table 162. Brazil Digital PCR and Real-time PCR, by End-user USD Million (2021-2026)
  • Table 163. Brazil Digital PCR and Real-time PCR, by Solution USD Million (2021-2026)
  • Table 164. Argentina Digital PCR and Real-time PCR, by Type USD Million (2021-2026)
  • Table 165. Argentina Digital PCR and Real-time PCR, by Application USD Million (2021-2026)
  • Table 166. Argentina Digital PCR and Real-time PCR, by End-user USD Million (2021-2026)
  • Table 167. Argentina Digital PCR and Real-time PCR, by Solution USD Million (2021-2026)
  • Table 168. Rest of South America Digital PCR and Real-time PCR, by Type USD Million (2021-2026)
  • Table 169. Rest of South America Digital PCR and Real-time PCR, by Application USD Million (2021-2026)
  • Table 170. Rest of South America Digital PCR and Real-time PCR, by End-user USD Million (2021-2026)
  • Table 171. Rest of South America Digital PCR and Real-time PCR, by Solution USD Million (2021-2026)
  • Table 172. Asia Pacific Digital PCR and Real-time PCR, by Country USD Million (2021-2026)
  • Table 173. Asia Pacific Digital PCR and Real-time PCR, by Type USD Million (2021-2026)
  • Table 174. Asia Pacific Digital PCR and Real-time PCR, by Application USD Million (2021-2026)
  • Table 175. Asia Pacific Digital PCR and Real-time PCR, by End-user USD Million (2021-2026)
  • Table 176. Asia Pacific Digital PCR and Real-time PCR, by Solution USD Million (2021-2026)
  • Table 177. China Digital PCR and Real-time PCR, by Type USD Million (2021-2026)
  • Table 178. China Digital PCR and Real-time PCR, by Application USD Million (2021-2026)
  • Table 179. China Digital PCR and Real-time PCR, by End-user USD Million (2021-2026)
  • Table 180. China Digital PCR and Real-time PCR, by Solution USD Million (2021-2026)
  • Table 181. Japan Digital PCR and Real-time PCR, by Type USD Million (2021-2026)
  • Table 182. Japan Digital PCR and Real-time PCR, by Application USD Million (2021-2026)
  • Table 183. Japan Digital PCR and Real-time PCR, by End-user USD Million (2021-2026)
  • Table 184. Japan Digital PCR and Real-time PCR, by Solution USD Million (2021-2026)
  • Table 185. India Digital PCR and Real-time PCR, by Type USD Million (2021-2026)
  • Table 186. India Digital PCR and Real-time PCR, by Application USD Million (2021-2026)
  • Table 187. India Digital PCR and Real-time PCR, by End-user USD Million (2021-2026)
  • Table 188. India Digital PCR and Real-time PCR, by Solution USD Million (2021-2026)
  • Table 189. South Korea Digital PCR and Real-time PCR, by Type USD Million (2021-2026)
  • Table 190. South Korea Digital PCR and Real-time PCR, by Application USD Million (2021-2026)
  • Table 191. South Korea Digital PCR and Real-time PCR, by End-user USD Million (2021-2026)
  • Table 192. South Korea Digital PCR and Real-time PCR, by Solution USD Million (2021-2026)
  • Table 193. Taiwan Digital PCR and Real-time PCR, by Type USD Million (2021-2026)
  • Table 194. Taiwan Digital PCR and Real-time PCR, by Application USD Million (2021-2026)
  • Table 195. Taiwan Digital PCR and Real-time PCR, by End-user USD Million (2021-2026)
  • Table 196. Taiwan Digital PCR and Real-time PCR, by Solution USD Million (2021-2026)
  • Table 197. Australia Digital PCR and Real-time PCR, by Type USD Million (2021-2026)
  • Table 198. Australia Digital PCR and Real-time PCR, by Application USD Million (2021-2026)
  • Table 199. Australia Digital PCR and Real-time PCR, by End-user USD Million (2021-2026)
  • Table 200. Australia Digital PCR and Real-time PCR, by Solution USD Million (2021-2026)
  • Table 201. Rest of Asia-Pacific Digital PCR and Real-time PCR, by Type USD Million (2021-2026)
  • Table 202. Rest of Asia-Pacific Digital PCR and Real-time PCR, by Application USD Million (2021-2026)
  • Table 203. Rest of Asia-Pacific Digital PCR and Real-time PCR, by End-user USD Million (2021-2026)
  • Table 204. Rest of Asia-Pacific Digital PCR and Real-time PCR, by Solution USD Million (2021-2026)
  • Table 205. Europe Digital PCR and Real-time PCR, by Country USD Million (2021-2026)
  • Table 206. Europe Digital PCR and Real-time PCR, by Type USD Million (2021-2026)
  • Table 207. Europe Digital PCR and Real-time PCR, by Application USD Million (2021-2026)
  • Table 208. Europe Digital PCR and Real-time PCR, by End-user USD Million (2021-2026)
  • Table 209. Europe Digital PCR and Real-time PCR, by Solution USD Million (2021-2026)
  • Table 210. Germany Digital PCR and Real-time PCR, by Type USD Million (2021-2026)
  • Table 211. Germany Digital PCR and Real-time PCR, by Application USD Million (2021-2026)
  • Table 212. Germany Digital PCR and Real-time PCR, by End-user USD Million (2021-2026)
  • Table 213. Germany Digital PCR and Real-time PCR, by Solution USD Million (2021-2026)
  • Table 214. France Digital PCR and Real-time PCR, by Type USD Million (2021-2026)
  • Table 215. France Digital PCR and Real-time PCR, by Application USD Million (2021-2026)
  • Table 216. France Digital PCR and Real-time PCR, by End-user USD Million (2021-2026)
  • Table 217. France Digital PCR and Real-time PCR, by Solution USD Million (2021-2026)
  • Table 218. Italy Digital PCR and Real-time PCR, by Type USD Million (2021-2026)
  • Table 219. Italy Digital PCR and Real-time PCR, by Application USD Million (2021-2026)
  • Table 220. Italy Digital PCR and Real-time PCR, by End-user USD Million (2021-2026)
  • Table 221. Italy Digital PCR and Real-time PCR, by Solution USD Million (2021-2026)
  • Table 222. United Kingdom Digital PCR and Real-time PCR, by Type USD Million (2021-2026)
  • Table 223. United Kingdom Digital PCR and Real-time PCR, by Application USD Million (2021-2026)
  • Table 224. United Kingdom Digital PCR and Real-time PCR, by End-user USD Million (2021-2026)
  • Table 225. United Kingdom Digital PCR and Real-time PCR, by Solution USD Million (2021-2026)
  • Table 226. Netherlands Digital PCR and Real-time PCR, by Type USD Million (2021-2026)
  • Table 227. Netherlands Digital PCR and Real-time PCR, by Application USD Million (2021-2026)
  • Table 228. Netherlands Digital PCR and Real-time PCR, by End-user USD Million (2021-2026)
  • Table 229. Netherlands Digital PCR and Real-time PCR, by Solution USD Million (2021-2026)
  • Table 230. Rest of Europe Digital PCR and Real-time PCR, by Type USD Million (2021-2026)
  • Table 231. Rest of Europe Digital PCR and Real-time PCR, by Application USD Million (2021-2026)
  • Table 232. Rest of Europe Digital PCR and Real-time PCR, by End-user USD Million (2021-2026)
  • Table 233. Rest of Europe Digital PCR and Real-time PCR, by Solution USD Million (2021-2026)
  • Table 234. MEA Digital PCR and Real-time PCR, by Country USD Million (2021-2026)
  • Table 235. MEA Digital PCR and Real-time PCR, by Type USD Million (2021-2026)
  • Table 236. MEA Digital PCR and Real-time PCR, by Application USD Million (2021-2026)
  • Table 237. MEA Digital PCR and Real-time PCR, by End-user USD Million (2021-2026)
  • Table 238. MEA Digital PCR and Real-time PCR, by Solution USD Million (2021-2026)
  • Table 239. Middle East Digital PCR and Real-time PCR, by Type USD Million (2021-2026)
  • Table 240. Middle East Digital PCR and Real-time PCR, by Application USD Million (2021-2026)
  • Table 241. Middle East Digital PCR and Real-time PCR, by End-user USD Million (2021-2026)
  • Table 242. Middle East Digital PCR and Real-time PCR, by Solution USD Million (2021-2026)
  • Table 243. Africa Digital PCR and Real-time PCR, by Type USD Million (2021-2026)
  • Table 244. Africa Digital PCR and Real-time PCR, by Application USD Million (2021-2026)
  • Table 245. Africa Digital PCR and Real-time PCR, by End-user USD Million (2021-2026)
  • Table 246. Africa Digital PCR and Real-time PCR, by Solution USD Million (2021-2026)
  • Table 247. North America Digital PCR and Real-time PCR, by Country USD Million (2021-2026)
  • Table 248. North America Digital PCR and Real-time PCR, by Type USD Million (2021-2026)
  • Table 249. North America Digital PCR and Real-time PCR, by Application USD Million (2021-2026)
  • Table 250. North America Digital PCR and Real-time PCR, by End-user USD Million (2021-2026)
  • Table 251. North America Digital PCR and Real-time PCR, by Solution USD Million (2021-2026)
  • Table 252. United States Digital PCR and Real-time PCR, by Type USD Million (2021-2026)
  • Table 253. United States Digital PCR and Real-time PCR, by Application USD Million (2021-2026)
  • Table 254. United States Digital PCR and Real-time PCR, by End-user USD Million (2021-2026)
  • Table 255. United States Digital PCR and Real-time PCR, by Solution USD Million (2021-2026)
  • Table 256. Canada Digital PCR and Real-time PCR, by Type USD Million (2021-2026)
  • Table 257. Canada Digital PCR and Real-time PCR, by Application USD Million (2021-2026)
  • Table 258. Canada Digital PCR and Real-time PCR, by End-user USD Million (2021-2026)
  • Table 259. Canada Digital PCR and Real-time PCR, by Solution USD Million (2021-2026)
  • Table 260. Mexico Digital PCR and Real-time PCR, by Type USD Million (2021-2026)
  • Table 261. Mexico Digital PCR and Real-time PCR, by Application USD Million (2021-2026)
  • Table 262. Mexico Digital PCR and Real-time PCR, by End-user USD Million (2021-2026)
  • Table 263. Mexico Digital PCR and Real-time PCR, by Solution USD Million (2021-2026)
  • Table 264. Digital PCR and Real-time PCR: by Type(USD/Units)
  • Table 265. Research Programs/Design for This Report
  • Table 266. Key Data Information from Secondary Sources
  • Table 267. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Digital PCR and Real-time PCR: by Type USD Million (2015-2020)
  • Figure 5. Global Digital PCR and Real-time PCR: by Application USD Million (2015-2020)
  • Figure 6. Global Digital PCR and Real-time PCR: by End-user USD Million (2015-2020)
  • Figure 7. Global Digital PCR and Real-time PCR: by Solution USD Million (2015-2020)
  • Figure 8. South America Digital PCR and Real-time PCR Share (%), by Country
  • Figure 9. Asia Pacific Digital PCR and Real-time PCR Share (%), by Country
  • Figure 10. Europe Digital PCR and Real-time PCR Share (%), by Country
  • Figure 11. MEA Digital PCR and Real-time PCR Share (%), by Country
  • Figure 12. North America Digital PCR and Real-time PCR Share (%), by Country
  • Figure 13. Global Digital PCR and Real-time PCR: by Type USD/Units (2015-2020)
  • Figure 14. Global Digital PCR and Real-time PCR share by Players 2020 (%)
  • Figure 15. Global Digital PCR and Real-time PCR share by Players (Top 3) 2020(%)
  • Figure 16. Global Digital PCR and Real-time PCR share by Players (Top 5) 2020(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Thermo Fisher Scientific, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Thermo Fisher Scientific, Inc. (United States) Revenue: by Geography 2020
  • Figure 20. F. Hoffman-La Roche Ltd. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 21. F. Hoffman-La Roche Ltd. (Switzerland) Revenue: by Geography 2020
  • Figure 22. Bio-Rad Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. Bio-Rad Laboratories, Inc. (United States) Revenue: by Geography 2020
  • Figure 24. QIAGEN N.V. (Germany) Revenue, Net Income and Gross profit
  • Figure 25. QIAGEN N.V. (Germany) Revenue: by Geography 2020
  • Figure 26. Takara Bio, Inc. (Japan) Revenue, Net Income and Gross profit
  • Figure 27. Takara Bio, Inc. (Japan) Revenue: by Geography 2020
  • Figure 28. Agilent Technologies, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. Agilent Technologies, Inc. (United States) Revenue: by Geography 2020
  • Figure 30. BioMérieux S.A. (France) Revenue, Net Income and Gross profit
  • Figure 31. BioMérieux S.A. (France) Revenue: by Geography 2020
  • Figure 32. Fluidigm Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 33. Fluidigm Corporation (United States) Revenue: by Geography 2020
  • Figure 34. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 35. Danaher Corporation (United States) Revenue: by Geography 2020
  • Figure 36. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 37. Abbott Laboratories (United States) Revenue: by Geography 2020
  • Figure 38. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 39. Merck KGaA (Germany) Revenue: by Geography 2020
  • Figure 40. Becton Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 41. Becton Dickinson and Company (United States) Revenue: by Geography 2020
  • Figure 42. Global Digital PCR and Real-time PCR: by Type USD Million (2021-2026)
  • Figure 43. Global Digital PCR and Real-time PCR: by Application USD Million (2021-2026)
  • Figure 44. Global Digital PCR and Real-time PCR: by End-user USD Million (2021-2026)
  • Figure 45. Global Digital PCR and Real-time PCR: by Solution USD Million (2021-2026)
  • Figure 46. South America Digital PCR and Real-time PCR Share (%), by Country
  • Figure 47. Asia Pacific Digital PCR and Real-time PCR Share (%), by Country
  • Figure 48. Europe Digital PCR and Real-time PCR Share (%), by Country
  • Figure 49. MEA Digital PCR and Real-time PCR Share (%), by Country
  • Figure 50. North America Digital PCR and Real-time PCR Share (%), by Country
  • Figure 51. Global Digital PCR and Real-time PCR: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Thermo Fisher Scientific, Inc. (United States)
  • F. Hoffman-La Roche Ltd. (Switzerland)
  • Bio-Rad Laboratories, Inc. (United States)
  • QIAGEN N.V. (Germany)
  • Takara Bio, Inc. (Japan)
  • Agilent Technologies, Inc. (United States)
  • BioMérieux S.A. (France)
  • Fluidigm Corporation (United States)
  • Danaher Corporation (United States)
  • Abbott Laboratories (United States)
  • Merck KGaA (Germany)
  • Becton Dickinson and Company (United States)
Additional players considered in the study are as follows:
Promega Corporation (United States) , Eppendorf AG (Germany) , Analytik Jena AG (Germany)
Select User Access Type

Key Highlights of Report


Oct 2021 226 Pages 60 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Digital PCR and Real-time PCR Market Quantitative research analysis
Global Digital PCR and Real-time PCR Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Growing Prevalence of Genetic Disorders " is seen as one of major growth factors of Digital PCR and Real-time PCR Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
United States will lead Digital PCR and Real-time PCR Market in coming years.

Know More About Global Digital PCR and Real-time PCR Market Report?

Have a Query? Click Here

Other Related Reports

Analytical Standards Comprehensive Study by Type (Organic Standards, Inorganic Standards), Application (Food & Beverage, Environmental, Pharmaceutical, Cosmetic, Veterinary, Forensic), Technique (Chr...
$ 3450
2D Chromatography Comprehensive Study by Type (2D Gas Chromatography (GC), 2D Liquid Chromatography (LC)), Application (Life science research, Environmental analysis, Food and Beverage Testing, Petro...
$ 3750
Pharmaceutical Contract Manufacturing Comprehensive Study by Type (Active Pharmaceutical Ingredients (API), Finished Dosage Formulations (FDF) (Tablet, Capsule, Oral Liquids, Parenteral/Injectable, O...
$ 3750
Bioinformatics Comprehensive Study by Type (Knowledge Management Tools, Bioinformatics Platforms, Bioinformatics Services), Application (Genomics, Chemoinformatics & Drug design, Proteomics, Transcri...
$ 3750
Vaccine Contract Manufacturing Comprehensive Study by Type (Attenuated Vaccine, Inactivated Vaccine, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines), Application (Mammalian, Microbial, Others), Scal...
$ 3750
Clinical Trial Management System (CTMS) Comprehensive Study by Type (Enterprise CTMS, Site CTMS), Application (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations (CRO), M...
$ 3750